Ptc Therapeutics earnings were -$363.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest PTCT earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$65.9M, down 38.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PTCT reported annual earnings of -$363.3M, with -42% growth. The next PTCT earnings date is Apr 23, 2025.
What were Ptc Therapeutics's earnings last quarter?
On PTCT's earnings call on Invalid Date, Ptc Therapeutics (NASDAQ: PTCT) reported Q4 2024 earnings per share (EPS) of -$0.85, up 58.74% year over year. Total PTCT earnings for the quarter were -$65.89 million. In the same quarter last year, Ptc Therapeutics's earnings per share (EPS) was -$2.06.
The next PTCT earnings date is Invalid Date. Add PTCT to your watchlist to be reminded of Ptc Therapeutics's next earnings date.
What was PTCT's earnings growth in the past year?
As of Ptc Therapeutics's earnings date in Invalid Date, Ptc Therapeutics's earnings has grown year over year. PTCT earnings in the past year totalled -$363.30 million.
Is Ptc Therapeutics profitable or losing money?
As of the last Ptc Therapeutics earnings report, Ptc Therapeutics is currently losing money. Ptc Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$363.30 million, a 42.02% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.